Cabaletta Bio, Inc. (CABA)

Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $225.92 million. The enterprise value is $56.13 million.

Market Cap	225.92M
Enterprise Value	56.13M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Cabaletta Bio has 91.47 million shares outstanding. The number of shares has increased by 11.81% in one year.

Current Share Class	91.47M
Shares Outstanding	91.47M
Shares Change (YoY)	+11.81%
Shares Change (QoQ)	+21.94%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	53.27%
Float	61.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.27
P/TBV Ratio	1.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.14.

Current Ratio	4.78
Quick Ratio	4.69
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-92.92

Financial Efficiency

Return on equity (ROE) is -76.34% and return on invested capital (ROIC) is -45.66%.

Return on Equity (ROE)	-76.34%
Return on Assets (ROA)	-42.39%
Return on Invested Capital (ROIC)	-45.66%
Return on Capital Employed (ROCE)	-81.92%
Revenue Per Employee	n/a
Profits Per Employee	-$879,793
Employee Count	164
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.48% in the last 52 weeks. The beta is 2.85, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y)	2.85
52-Week Price Change	-43.48%
50-Day Moving Average	1.68
200-Day Moving Average	1.86
Relative Strength Index (RSI)	79.66
Average Volume (20 Days)	2,097,663

Short Selling Information

The latest short interest is 5.82 million, so 6.37% of the outstanding shares have been sold short.

Short Interest	5.82M
Short Previous Month	6.31M
Short % of Shares Out	6.37%
Short % of Float	9.45%
Short Ratio (days to cover)	4.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-149.87M
Pretax Income	-144.29M
Net Income	-144.29M
EBITDA	-148.03M
EBIT	-149.87M
Earnings Per Share (EPS)	-$2.75

Balance Sheet

The company has $194.68 million in cash and $24.89 million in debt, giving a net cash position of $169.79 million or $1.86 per share.

Cash & Cash Equivalents	194.68M
Total Debt	24.89M
Net Cash	169.79M
Net Cash Per Share	$1.86
Equity (Book Value)	178.48M
Book Value Per Share	1.95
Working Capital	156.87M

Cash Flow

In the last 12 months, operating cash flow was -$104.67 million and capital expenditures -$1.58 million, giving a free cash flow of -$106.25 million.

Operating Cash Flow	-104.67M
Capital Expenditures	-1.58M
Free Cash Flow	-106.25M
FCF Per Share	-$1.16

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.81%
Shareholder Yield	-11.81%
Earnings Yield	-63.87%
FCF Yield	-47.03%

Analyst Forecast

The average price target for Cabaletta Bio is $12.75, which is 416.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.75
Price Target Difference	416.19%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-25.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1